Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Efsubaglutide Alfa

LIGHT

Shanghai Yinnuo Pharmaceutical Technology Co · Phase 2 · Completed · Enrollment 50

NCT06732960

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Efsubaglutide Alfa 5mgn/rn/rn/rn/rn/r
Efsubaglutide Alfa 7.5mgn/rn/rn/rn/rn/r
Efsubaglutide Alfa 10mgn/rn/rn/rn/rn/r
Efsubaglutide Alfa 15mgn/rn/rn/rn/rn/r
Efsubaglutide Alfa 20mgn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.